Serum miR-21 putative biomarker for colorectal cancer

June 20, 2013
Serum <i>miR-21</i> putative biomarker for colorectal cancer
The oncogenic microRNA miR-21 is a potential biomarker for detection and prognosis of colorectal cancer, according to a study published in the June 19 issue of the Journal of the National Cancer Institute.

(HealthDay)—The oncogenic microRNA (miRNA) miR-21 is a potential biomarker for detection and prognosis of colorectal cancer (CRC), according to a study published in the June 19 issue of the Journal of the National Cancer Institute.

Yuji Toiyama, from the Baylor University Medical Center in Dallas, and colleagues screened for expression of miR-21 and miR-31 in two CRC cell lines and in serum from 12 patients with CRC and 12 controls. Expression of candidate miRNAs was validated in serum samples from an independent cohort of 186 patients with CRC, 60 postoperative patients, 43 patients with advanced adenoma, and 53 controls. To determine whether serum miRNAs reflect expression in CRC, miR-21 expression was analyzed in 166 matched primary CRC tissues.

The researchers found that miR-21 was secreted from CRC cell lines and upregulated in serum from CRC patients. In patients with adenomas and CRCs from the validation cohort, miR-21 expression was significantly elevated in preoperative serum, and expression decreased in postoperative serum from patients who underwent curative surgery. Serum miR-21 levels differentiated patients with adenoma and CRC from control patients (area under the curve, 0.813 and 0.919, respectively). There was a significant correlation between high serum and tissue miR-21 expression with , distant metastases, and poor survival. Serum miR-21 was a significant for CRC, with a hazard ratio of 4.12.

"Our results provide compelling evidence for the potential usefulness of serum miR-21 as a noninvasive screening and prognostic tool in patients with , a concept that can be incorporated into routine clinical practice in the not-so-distant future pending validation in large-scale prospective trials," the authors write.

Explore further: A potential biomarker for pregnancy-associated heart disease?

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

A potential biomarker for pregnancy-associated heart disease?

April 24, 2013
Peripartum cardiomyopathy (PPCM) is a deterioration in cardiac function that occurs in pregnant women during the last month or in the months following their pregnancy. This disorder can occur in women with no prior history ...

Biomarker identification may lead to new noninvasive test for colorectal cancer detection

June 7, 2013
The average 5-year survival for colorectal cancer (CRC) is less than 10% if metastasis occurs, but can reach 90% if detected early. A new non-invasive test has been developed that measures methylation of the SDC2 gene in ...

Genetic CRC risk likely mediated by differential adenoma risk

January 10, 2013
(HealthDay)—Much of the genetic risk for colorectal cancer (CRC) in the general population is mediated by differential adenoma risk, according to research published in the January issue of Gastroenterology.

Comprehensive discussion with docs ups cancer screening

April 29, 2013
(HealthDay)—Having more comprehensive discussions about colorectal cancer (CRC) screening with primary care providers (PCPs) is associated with increased odds of screening, according to a study published in the April issue ...

Study identifies possible new acute leukemia marker, treatment target

May 13, 2013
A study has identified microRNA-155 as a new independent prognostic marker and treatment target in patients with acute myeloid leukemia that has normal-looking chromosomes under the microscope (that is, cytogenetically normal ...

MicroRNA molecule may serve as biomarker, target for brain metastases in breast cancer patients

February 5, 2013
Researchers have identified two molecules that could potentially serve as biomarkers in predicting brain metastases in patients with breast cancer, according to data published in Cancer Research, a publication of the American ...

Recommended for you

How cancer metastasis happens: Researchers reveal a key mechanism

January 18, 2018
Cancer metastasis, the migration of cells from a primary tumor to form distant tumors in the body, can be triggered by a chronic leakage of DNA within tumor cells, according to a team led by Weill Cornell Medicine and Memorial ...

Modular gene enhancer promotes leukemia and regulates effectiveness of chemotherapy

January 18, 2018
Every day, billions of new blood cells are generated in the bone marrow. The gene Myc is known to play an important role in this process, and is also known to play a role in cancer. Scientists from the German Cancer Research ...

These foods may up your odds for colon cancer

January 18, 2018
(HealthDay)—Chowing down on red meat, white bread and sugar-laden drinks might increase your long-term risk of colon cancer, a new study suggests.

The pill lowers ovarian cancer risk, even for smokers

January 18, 2018
(HealthDay)—It's known that use of the birth control pill is tied to lower odds for ovarian cancer, but new research shows the benefit extends to smokers or women who are obese.

Researchers develop swallowable test to detect pre-cancerous Barrett's esophagus

January 17, 2018
Investigators at Case Western Reserve University School of Medicine and University Hospitals Cleveland Medical Center have developed a simple, swallowable test for early detection of Barrett's esophagus that offers promise ...

Scientists zoom in to watch DNA code being read

January 17, 2018
Scientists have unveiled incredible images of how the DNA code is read and interpreted—revealing new detail about one of the fundamental processes of life.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.